After the COVID-19 pandemic severely impacted much of its business, Bioventus is on something of a growth spurt this year. Just over a month after going public, the orthopedic therapy developer has ...

Bioventus Inc. has acquired medical devices provider Bioness Inc. for a total consideration of $110 million. This includes an up-front payment of $45 million and milestone payments of up to $65 ...

VALENCIA, Calif.--(BUSINESS WIRE)--Bioness Inc., a leading neuromodulation company, announced today two agreements to distribute new devices for patients experiencing neurological impairment. Through ...

DUBLIN, June 21, 2021 /PRNewswire/ -- The "Neurorehabilitation Devices - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19 crisis, the ...